// App-Quantinova.ai

3882 : Patient-specific druggable networks in lethal prostate cancer through proteome-guided multi-omic integration

Researchers

Presenter

  • Justin M. Drake

Principal Investigators

  • Evan O. Paull

  • Nicholas A. Graham

  • John K. Lee

  • Bryan A. Smith

  • Tanya Stoyanova

  • Claire M. Faltermeier

  • Daniel E. Carlin

  • Ajay Vashisht

  • Jiaoti Huang

  • James A. Wohlschlegel

  • Thomas G. Graeber

  • Owen N. Witte

  • Joshua M. Stuart

Medical Centers

  • Rutgers Cancer Institute of New Jersey, New Brunswick, NJ

  • University of California, Santa Cruz, Santa Cruz, CA

  • University of Southern California, Los Angeles, CA

  • University of Southern California, Los Angeles, CA

  • University of California, San Diego, La Jolla, CA

  • Duke University, Durham, NC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Metastatic castration-resistant prostate cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Androgen Tear

  • Tamsulosin Hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved